MEGAN ROBERTSON: Open Payments
NPI 1912520438 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$533 in 27 payments from 18 companies in 2025. Trend: 2023 $42 · 2024 $566 · 2025 $533
Food & beverage: $533
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $101 |
| Abbott Laboratories | 1 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| ABBVIE INC. | 2 | $43 |
| Corcept Therapeutics | 3 | $43 |
| Lilly USA, LLC | 2 | $38 |
| Eisai Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Biogen, Inc. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: CAPLYTA, FREESTYLE LIBRE 3, REXULTI, VRAYLAR, Korlym, MOUNJARO, Leqembi, TRELEGY ELLIPTA.
Industry payments across KS — which companies pay providers there.
